1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Type 2 Diabetes Global Clinical Trials Review, H1, 2014

Type 2 Diabetes Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Type 2 Diabetes Global Clinical Trials Review, H1, 2014" provides data on the Type 2 Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 2 Diabetes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Type 2 Diabetes Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Type 2 Diabetes 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Type 2 Diabetes 26
Subjects Recruited Over a Period of Time 56
Clinical Trials by Sponsor Type 57
Prominent Sponsors 58
Top Companies Participating in Type 2 Diabetes Therapeutics Clinical Trials 59
Prominent Drugs 61
Latest Clinical Trials News on Type 2 Diabetes 62
May 15, 2014: Transition Therapeutics Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study 62
May 14, 2014: Isis Pharmaceuticals Reports Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c in Patients With Type 2 Diabetes 62
May 13, 2014: AstraZeneca announces positive results from Phase III study of saxagliptin/dapagliflozin combination in patients with type 2 diabetes inadequately controlled on metformin and outlines future development plans for the oral antidiabetic franchise 63
May 12, 2014: Xenetic Biosciences Announces Positive Phase 1 Clinical Results for PSA-Oxyntomodulin for the Treatment of Type II Diabetes and Obesity 64
May 12, 2014: Lilly's Basal Insulin Peglispro Shows Superiority in HbA1c Reduction Compared to Insulin Glargine in Three Phase III Trials in Patients with Type 2 Diabetes 65
May 01, 2014: Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With High Triglycerides and Type 2 Diabetes 66
Apr 24, 2014: Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit 67
Apr 16, 2014: Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results for SGLT2 Inhibitor Remogliflozin Etabonate 68
Apr 09, 2014: Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro 68
Apr 03, 2014: ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease 70
Mar 30, 2014: Higher risks without cardio benefits halt study of aleglitazar 71
Mar 19, 2014: Hua Medicine's Novel Glucokinase Activator Reports Positive Phase 1a Data Demonstrating Robust Glucose Regulatory Hormone Modulation and Commences Phase 1b Trials in Diabetes Patients 71
Mar 17, 2014: Theracos Reports Positive Outcomes from a 96-Week Phase 2 Study of THR1442, a Highly Specific SGLT2 Inhibitor, for the Treatment of Type 2 Diabetes 72
Mar 10, 2014: Fibrotech announces positive Phase Ia results for anti-fibrotic FT011 73
Mar 04, 2014: Boston Therapeutics to Initiate a Phase II Clinical Study of BTI-320 in U.S. 73
Mar 04, 2014: Novo Nordisk Successfully Completes Phase I Trial of its Proprietary Oral Insulin using Merrion Pharmaceuticals' GIPET Technology. 74
Clinical Trial Profiles 75
Clinical Trial Overview of Top Companies 75
Novo A/S 75
Clinical Trial Overview of Novo A/S 75
Eli Lilly and Company 103
Clinical Trial Overview of Eli Lilly and Company 103
Bristol-Myers Squibb Company 121
Clinical Trial Overview of Bristol-Myers Squibb Company 121
Merck and Co., Inc. 139
Clinical Trial Overview of Merck and Co., Inc. 139
Sanofi 154
Clinical Trial Overview of Sanofi 154
Novartis AG 166
Clinical Trial Overview of Novartis AG 166
AstraZeneca PLC 179
Clinical Trial Overview of AstraZeneca PLC 179
GlaxoSmithKline plc 191
Clinical Trial Overview of GlaxoSmithKline plc 191
Takeda Pharmaceutical Company Limited 201
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 201
Pfizer Inc. 211
Clinical Trial Overview of Pfizer Inc. 211
Clinical Trial Overview of Top Institutes / Government 220
The National Institute of Diabetes and Digestive and Kidney Diseases 220
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 220
Tehran University of Medical Sciences 223
Clinical Trial Overview of Tehran University of Medical Sciences 223
Juntendo University School of Medicine 226
Clinical Trial Overview of Juntendo University School of Medicine 226
Maastricht University Medical Center 228
Clinical Trial Overview of Maastricht University Medical Center 228
U.S. Department of Veterans Affairs 230
Clinical Trial Overview of U.S. Department of Veterans Affairs 230
Aarhus University 232
Clinical Trial Overview of Aarhus University 232
National Heart, Lung, and Blood Institute 234
Clinical Trial Overview of National Heart, Lung, and Blood Institute 234
Washington University School of Medicine 236
Clinical Trial Overview of Washington University School of Medicine 236
Vanderbilt University 237
Clinical Trial Overview of Vanderbilt University 237
Academic Medical Center 238
Clinical Trial Overview of Academic Medical Center 238
Five Key Clinical Profiles 240
Appendix 317
Abbreviations 317
Definitions 317
Research Methodology 318
Secondary Research 318
About GlobalData 319
Contact Us 319
Disclaimer 319
Source 319

List of Tables
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Region, 2014* 8
Type 2 Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Type 2 Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 11
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 12
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2014* 13
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 14
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 15
Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 16
Type 2 Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Type 2 Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 19
Type 2 Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Type 2 Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Phase, 2014* 22
Type 2 Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 23
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Type 2 Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Type 2 Diabetes Therapeutics, Global, Suspended Clinical Trials, 2014* 26
Type 2 Diabetes Therapeutics, Global, Withdrawn Clinical Trials, 2014* 29
Type 2 Diabetes Therapeutics, Global, Terminated Clinical Trials, 2014* 33
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 56
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 57
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 58
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 60
Type 2 Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 61
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014* 75
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 103
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 121
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 139
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 154
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 166
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 179
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 191
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 201
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 211
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 220
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 223
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2014* 226
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 228
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 230
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 232
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 234
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 236
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 237
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 238

List of Figures
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Region (%), 2014* 8
Type 2 Diabetes Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 9
Type 2 Diabetes Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 10
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 11
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 12
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 13
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 14
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 15
Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 16
Type 2 Diabetes Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 17
Type 2 Diabetes Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 18
Proportion of Type 2 Diabetes to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 19
Type 2 Diabetes Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 20
Type 2 Diabetes Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 21
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Phase (%), 2014* 22
Type 2 Diabetes Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 23
Type 2 Diabetes Therapeutics, Global, Clinical Trials by Trial Status, 2014* 24
Type 2 Diabetes Therapeutics Clinical Trials, Global, by End Point Status, 2014* 25
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 56
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 57
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 58
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 59
Type 2 Diabetes Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 61
GlobalData Methodology 318

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

  • $ 4995
  • Industry report
  • August 2016
  • by GBI Research

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Summary Diabetes is a chronic metabolic disease ...

Global Needle Free Diabetes Management Market Analysis & Trends – Device Type (Artificial Pancreas Devices & Systems, Diagnostic Devices, Treatment Devices), Management Type - Forecast to 2025

Global Needle Free Diabetes Management Market Analysis & Trends – Device Type (Artificial Pancreas Devices & Systems, Diagnostic Devices, Treatment Devices), Management Type - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Needle Free Diabetes Management Market is poised to grow at a CAGR of around 17.6% over the next decade to reach approximately $16.2 billion by 2025. Some of the prominent trends that the market ...

Global Diabetes Management Market Report 2016

Global Diabetes Management Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions (North ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.